| Page 37 | Kisaco Research

When innovation moves faster than policy, the path to market calls for creative approaches. Tammie Wahaus, CEO of ELIAS Animal Health, shares how her team advances pivotal trials, adapts human health technologies, and keeps development on track as regulatory expectations continue to evolve.

Biopharma
USDA
Oncology
Canine
Regulation
Immunotherapy
Treatment
Companion
Milestone - Shifting Regulatory Landscape

Author:

Tammie Wahaus

Chief Executive Officer
ELIAS Animal Health

Tammie Wahaus

Chief Executive Officer
ELIAS Animal Health

Scaling livestock technology requires uniting innovation with effective distribution and farmer adoption. David Smith outlines how Ceres Tag’s open platform empowers universities, distributors, and next-generation producers to accelerate global adoption and data-driven impact.

2021 Showcase Finalist
Milestone - AI to Engage Customers
Technology
Livestock
Monitoring
AI
Partnerships
Farmer
Customer Adoption
Late Stage VC
Detection
Prevention
Distribution

Author:

Mr. David Smith

CEO & Executive Chair
Ceres Tag

Mr. David Smith

CEO & Executive Chair
Ceres Tag

A well-timed bridge investment can mean the difference between stalling and scaling. Dr. Asel Sartbaeva, CEO and co-founder of EnsiliTech, reflects on how family office support provided crucial bridge, enabled better deal terms, and positioned the company to close an oversubscribed £4.5 million round.

2024 Showcase Finalist
Milestone - Bridge Funding
Funding
Family Office
Companion and Livestock
Biopharma
Seed
Prevention
Treatment

Author:

Asel Sartbaeva

CEO
EnsiliTech

Asel Sartbaeva

CEO
EnsiliTech
 

Tom Weaver

Co-Founder & Chairman
PetMedix & ArkVax

Tom Weaver

Co-Founder & Chairman
PetMedix & ArkVax

Tom Weaver

Co-Founder & Chairman
PetMedix & ArkVax